Num | GO | Overlap | Size | P Value | Adj. P Value |
1 |
CHROMOSOME ORGANIZATION |
101 |
1009 |
2.097e-38 |
4.878e-35 |
2 |
REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER |
135 |
1784 |
1.405e-38 |
4.878e-35 |
3 |
POSITIVE REGULATION OF GENE EXPRESSION |
128 |
1733 |
2.817e-35 |
4.37e-32 |
4 |
POSITIVE REGULATION OF BIOSYNTHETIC PROCESS |
130 |
1805 |
9.465e-35 |
1.101e-31 |
5 |
NEGATIVE REGULATION OF GENE EXPRESSION |
113 |
1493 |
9.484e-32 |
7.36e-29 |
6 |
CHROMATIN ORGANIZATION |
75 |
663 |
9.491e-32 |
7.36e-29 |
7 |
NEGATIVE REGULATION OF NITROGEN COMPOUND METABOLIC PROCESS |
112 |
1517 |
1.744e-30 |
1.159e-27 |
8 |
CELL CYCLE |
100 |
1316 |
5.108e-28 |
2.971e-25 |
9 |
CHROMATIN MODIFICATION |
63 |
539 |
1.84e-27 |
9.511e-25 |
10 |
CELLULAR RESPONSE TO DNA DAMAGE STIMULUS |
70 |
720 |
1.31e-25 |
6.096e-23 |
11 |
DNA METABOLIC PROCESS |
71 |
758 |
5.296e-25 |
2.24e-22 |
12 |
MITOTIC CELL CYCLE |
71 |
766 |
9.908e-25 |
3.842e-22 |
13 |
CELL CYCLE PROCESS |
85 |
1081 |
1.111e-24 |
3.975e-22 |
14 |
POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER |
81 |
1004 |
3.187e-24 |
1.059e-21 |
15 |
NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER |
68 |
740 |
1.781e-23 |
5.524e-21 |
16 |
CELLULAR RESPONSE TO STRESS |
102 |
1565 |
2.345e-23 |
6.819e-21 |
17 |
REGULATION OF CELL CYCLE |
77 |
949 |
3.618e-23 |
9.902e-21 |
18 |
REGULATION OF BINDING |
42 |
283 |
1.562e-22 |
4.037e-20 |
19 |
TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER |
65 |
724 |
6.633e-22 |
1.624e-19 |
20 |
COVALENT CHROMATIN MODIFICATION |
44 |
345 |
7.073e-21 |
1.646e-18 |
21 |
REGULATION OF CHROMOSOME ORGANIZATION |
39 |
278 |
4.223e-20 |
9.356e-18 |
22 |
REGULATION OF CELL CYCLE PROCESS |
54 |
558 |
9.321e-20 |
1.971e-17 |
23 |
REGULATION OF ORGANELLE ORGANIZATION |
80 |
1178 |
2.872e-19 |
5.811e-17 |
24 |
CELL CYCLE CHECKPOINT |
32 |
194 |
7.955e-19 |
1.542e-16 |
25 |
CHROMATIN REMODELING |
28 |
150 |
4.274e-18 |
7.955e-16 |
26 |
REGULATION OF MITOTIC CELL CYCLE |
47 |
468 |
6.101e-18 |
1.092e-15 |
27 |
CELL CYCLE PHASE TRANSITION |
35 |
255 |
7.652e-18 |
1.319e-15 |
28 |
PEPTIDYL AMINO ACID MODIFICATION |
63 |
841 |
2.834e-17 |
4.709e-15 |
29 |
REGULATION OF DNA METABOLIC PROCESS |
39 |
340 |
5.221e-17 |
8.377e-15 |
30 |
REGULATION OF CELL PROLIFERATION |
87 |
1496 |
1.013e-16 |
1.571e-14 |
31 |
NEGATIVE REGULATION OF CELL CYCLE PROCESS |
31 |
214 |
1.3e-16 |
1.927e-14 |
32 |
NEGATIVE REGULATION OF MITOTIC CELL CYCLE |
30 |
199 |
1.325e-16 |
1.927e-14 |
33 |
POSITIVE REGULATION OF CELL CYCLE |
38 |
332 |
1.438e-16 |
2.027e-14 |
34 |
NEGATIVE REGULATION OF CELL CYCLE |
43 |
433 |
2.565e-16 |
3.51e-14 |
35 |
REGULATION OF CELL CYCLE PHASE TRANSITION |
37 |
321 |
2.917e-16 |
3.878e-14 |
36 |
POSITIVE REGULATION OF CELL CYCLE PROCESS |
32 |
247 |
1.12e-15 |
1.448e-13 |
37 |
DNA INTEGRITY CHECKPOINT |
25 |
146 |
2.268e-15 |
2.852e-13 |
38 |
DNA CONFORMATION CHANGE |
33 |
273 |
3.109e-15 |
3.807e-13 |
39 |
REGULATION OF GENE EXPRESSION EPIGENETIC |
30 |
229 |
6.624e-15 |
7.903e-13 |
40 |
MITOTIC CELL CYCLE CHECKPOINT |
24 |
139 |
6.836e-15 |
7.952e-13 |
41 |
CELL DIVISION |
42 |
460 |
1.111e-14 |
1.261e-12 |
42 |
MITOTIC NUCLEAR DIVISION |
37 |
361 |
1.272e-14 |
1.409e-12 |
43 |
POSITIVE REGULATION OF ORGANELLE ORGANIZATION |
47 |
573 |
1.548e-14 |
1.659e-12 |
44 |
REGULATION OF DNA BINDING |
20 |
93 |
1.569e-14 |
1.659e-12 |
45 |
NEGATIVE REGULATION OF CELL CYCLE PHASE TRANSITION |
24 |
146 |
2.142e-14 |
2.215e-12 |
46 |
CHROMATIN ASSEMBLY OR DISASSEMBLY |
26 |
177 |
2.789e-14 |
2.822e-12 |
47 |
ORGANELLE FISSION |
43 |
496 |
3.249e-14 |
3.217e-12 |
48 |
PROTEIN DNA COMPLEX SUBUNIT ORGANIZATION |
29 |
229 |
4.62e-14 |
4.478e-12 |
49 |
DNA REPAIR |
42 |
480 |
4.797e-14 |
4.555e-12 |
50 |
REGULATION OF CHROMATIN ORGANIZATION |
24 |
152 |
5.409e-14 |
5.034e-12 |
51 |
INTERSPECIES INTERACTION BETWEEN ORGANISMS |
49 |
662 |
2.072e-13 |
1.854e-11 |
52 |
SYMBIOSIS ENCOMPASSING MUTUALISM THROUGH PARASITISM |
49 |
662 |
2.072e-13 |
1.854e-11 |
53 |
POSITIVE REGULATION OF CELL PROLIFERATION |
55 |
814 |
2.621e-13 |
2.301e-11 |
54 |
REGULATION OF CELL CYCLE ARREST |
20 |
108 |
3.178e-13 |
2.738e-11 |
55 |
POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION |
67 |
1152 |
6.031e-13 |
5.102e-11 |
56 |
REGULATION OF CELL DEATH |
78 |
1472 |
7.106e-13 |
5.904e-11 |
57 |
RESPONSE TO ENDOGENOUS STIMULUS |
77 |
1450 |
9.217e-13 |
7.524e-11 |
58 |
NEGATIVE REGULATION OF BINDING |
21 |
131 |
1.538e-12 |
1.234e-10 |
59 |
REGULATION OF DNA REPLICATION |
23 |
161 |
1.601e-12 |
1.262e-10 |
60 |
NEGATIVE REGULATION OF MOLECULAR FUNCTION |
63 |
1079 |
2.755e-12 |
2.137e-10 |
61 |
POSITIVE REGULATION OF CHROMOSOME ORGANIZATION |
22 |
150 |
2.863e-12 |
2.184e-10 |
62 |
CELLULAR RESPONSE TO LIPID |
38 |
457 |
3.891e-12 |
2.92e-10 |
63 |
POSITIVE REGULATION OF CELL CYCLE ARREST |
17 |
85 |
5.255e-12 |
3.881e-10 |
64 |
CELLULAR RESPONSE TO ORGANIC SUBSTANCE |
88 |
1848 |
6.69e-12 |
4.864e-10 |
65 |
MITOTIC DNA INTEGRITY CHECKPOINT |
18 |
100 |
8.148e-12 |
5.832e-10 |
66 |
REGULATION OF PROTEIN ACETYLATION |
15 |
64 |
8.31e-12 |
5.859e-10 |
67 |
RESPONSE TO ORGANIC CYCLIC COMPOUND |
56 |
917 |
9.106e-12 |
6.312e-10 |
68 |
RESPONSE TO ALCOHOL |
33 |
362 |
9.224e-12 |
6.312e-10 |
69 |
RESPONSE TO STEROID HORMONE |
39 |
497 |
1.186e-11 |
7.995e-10 |
70 |
DNA PACKAGING |
24 |
194 |
1.225e-11 |
8.145e-10 |
71 |
REGULATION OF NUCLEAR DIVISION |
22 |
163 |
1.561e-11 |
1.023e-09 |
72 |
REGULATION OF CELL DIVISION |
28 |
272 |
2.092e-11 |
1.352e-09 |
73 |
PEPTIDYL LYSINE MODIFICATION |
30 |
312 |
2.22e-11 |
1.415e-09 |
74 |
REGULATION OF PROTEIN BINDING |
22 |
168 |
2.867e-11 |
1.803e-09 |
75 |
REGULATION OF TRANSFERASE ACTIVITY |
56 |
946 |
3.056e-11 |
1.896e-09 |
76 |
SIGNAL TRANSDUCTION IN RESPONSE TO DNA DAMAGE |
17 |
96 |
4.091e-11 |
2.505e-09 |
77 |
CELL CYCLE G1 S PHASE TRANSITION |
18 |
111 |
5.044e-11 |
3.009e-09 |
78 |
G1 S TRANSITION OF MITOTIC CELL CYCLE |
18 |
111 |
5.044e-11 |
3.009e-09 |
79 |
DNA REPLICATION |
24 |
208 |
5.424e-11 |
3.195e-09 |
80 |
NEGATIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION |
17 |
98 |
5.76e-11 |
3.35e-09 |
81 |
G1 DNA DAMAGE CHECKPOINT |
15 |
73 |
6.301e-11 |
3.619e-09 |
82 |
REGULATION OF CELL DIFFERENTIATION |
74 |
1492 |
7.006e-11 |
3.976e-09 |
83 |
RESPONSE TO LIPID |
53 |
888 |
8.087e-11 |
4.533e-09 |
84 |
RESPONSE TO HORMONE |
53 |
893 |
9.928e-11 |
5.499e-09 |
85 |
REGULATION OF CELL CYCLE G1 S PHASE TRANSITION |
20 |
147 |
1.142e-10 |
6.254e-09 |
86 |
CELLULAR RESPONSE TO ENDOGENOUS STIMULUS |
57 |
1008 |
1.177e-10 |
6.368e-09 |
87 |
CELLULAR RESPONSE TO STEROID HORMONE STIMULUS |
24 |
218 |
1.455e-10 |
7.78e-09 |
88 |
REGULATION OF PROTEIN MODIFICATION PROCESS |
80 |
1710 |
1.767e-10 |
9.343e-09 |
89 |
RESPONSE TO ABIOTIC STIMULUS |
57 |
1024 |
2.144e-10 |
1.121e-08 |
90 |
REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING |
11 |
36 |
2.288e-10 |
1.183e-08 |
91 |
NEGATIVE REGULATION OF ORGANELLE ORGANIZATION |
32 |
387 |
2.393e-10 |
1.224e-08 |
92 |
AGING |
26 |
264 |
2.931e-10 |
1.482e-08 |
93 |
NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION |
44 |
684 |
3.663e-10 |
1.833e-08 |
94 |
NEGATIVE REGULATION OF CELL DEATH |
51 |
872 |
3.867e-10 |
1.914e-08 |
95 |
NEGATIVE REGULATION OF CHROMOSOME ORGANIZATION |
16 |
96 |
3.95e-10 |
1.935e-08 |
96 |
GLAND DEVELOPMENT |
32 |
395 |
4.016e-10 |
1.946e-08 |
97 |
GENE SILENCING |
23 |
212 |
4.735e-10 |
2.271e-08 |
98 |
SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR |
18 |
127 |
4.97e-10 |
2.36e-08 |
99 |
POSITIVE REGULATION OF CHROMATIN MODIFICATION |
15 |
85 |
6.095e-10 |
2.865e-08 |
100 |
RESPONSE TO OXYGEN CONTAINING COMPOUND |
68 |
1381 |
6.404e-10 |
2.98e-08 |
101 |
PROTEIN LOCALIZATION TO ORGANELLE |
38 |
556 |
1.173e-09 |
5.405e-08 |
102 |
POSITIVE REGULATION OF DNA METABOLIC PROCESS |
21 |
185 |
1.188e-09 |
5.421e-08 |
103 |
CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND |
34 |
465 |
1.646e-09 |
7.436e-08 |
104 |
CELL CYCLE G2 M PHASE TRANSITION |
18 |
138 |
1.965e-09 |
8.79e-08 |
105 |
NEGATIVE REGULATION OF PROTEIN BINDING |
14 |
79 |
2.159e-09 |
9.566e-08 |
106 |
POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS |
67 |
1395 |
2.419e-09 |
1.062e-07 |
107 |
CELL AGING |
13 |
67 |
2.541e-09 |
1.105e-07 |
108 |
POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS |
70 |
1492 |
2.673e-09 |
1.152e-07 |
109 |
DNA GEOMETRIC CHANGE |
14 |
81 |
3.037e-09 |
1.296e-07 |
110 |
POSITIVE REGULATION OF BINDING |
17 |
127 |
3.704e-09 |
1.567e-07 |
111 |
NEGATIVE REGULATION OF GENE EXPRESSION EPIGENETIC |
16 |
112 |
4.089e-09 |
1.714e-07 |
112 |
RESPONSE TO ESTRADIOL |
18 |
146 |
4.911e-09 |
2.04e-07 |
113 |
POSITIVE REGULATION OF DNA REPLICATION |
14 |
86 |
6.826e-09 |
2.811e-07 |
114 |
EMBRYO DEVELOPMENT |
49 |
894 |
7.381e-09 |
3.013e-07 |
115 |
POSITIVE REGULATION OF DEVELOPMENTAL PROCESS |
57 |
1142 |
1.157e-08 |
4.683e-07 |
116 |
RESPONSE TO DRUG |
31 |
431 |
1.296e-08 |
5.198e-07 |
117 |
CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND |
45 |
799 |
1.417e-08 |
5.636e-07 |
118 |
PROTEIN PHOSPHORYLATION |
50 |
944 |
1.551e-08 |
6.116e-07 |
119 |
POSITIVE REGULATION OF DNA BINDING |
10 |
42 |
2.23e-08 |
8.718e-07 |
120 |
RESPONSE TO ESTROGEN |
21 |
218 |
2.274e-08 |
8.819e-07 |
121 |
DNA TEMPLATED TRANSCRIPTION INITIATION |
20 |
202 |
3.107e-08 |
1.195e-06 |
122 |
PROTEIN ACETYLATION |
16 |
129 |
3.232e-08 |
1.227e-06 |
123 |
CELL DEVELOPMENT |
65 |
1426 |
3.244e-08 |
1.227e-06 |
124 |
NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS |
54 |
1087 |
3.428e-08 |
1.286e-06 |
125 |
MACROMOLECULAR COMPLEX ASSEMBLY |
64 |
1398 |
3.582e-08 |
1.333e-06 |
126 |
NUCLEOSOME DISASSEMBLY |
7 |
17 |
4.326e-08 |
1.56e-06 |
127 |
PROTEIN DNA COMPLEX DISASSEMBLY |
7 |
17 |
4.326e-08 |
1.56e-06 |
128 |
IMMUNE SYSTEM DEVELOPMENT |
36 |
582 |
4.287e-08 |
1.56e-06 |
129 |
CHROMATIN DISASSEMBLY |
7 |
17 |
4.326e-08 |
1.56e-06 |
130 |
REGULATION OF CELLULAR RESPONSE TO STRESS |
40 |
691 |
4.54e-08 |
1.625e-06 |
131 |
CELL PROLIFERATION |
39 |
672 |
6.306e-08 |
2.223e-06 |
132 |
TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER |
17 |
153 |
6.282e-08 |
2.223e-06 |
133 |
REGULATION OF SEQUENCE SPECIFIC DNA BINDING TRANSCRIPTION FACTOR ACTIVITY |
27 |
365 |
6.472e-08 |
2.264e-06 |
134 |
POSITIVE REGULATION OF PROTEIN ACETYLATION |
9 |
36 |
7.213e-08 |
2.505e-06 |
135 |
POSITIVE REGULATION OF MOLECULAR FUNCTION |
75 |
1791 |
8.319e-08 |
2.867e-06 |
136 |
DNA RECOMBINATION |
20 |
215 |
8.797e-08 |
3.01e-06 |
137 |
REGULATION OF TRANSCRIPTION INVOLVED IN G1 S TRANSITION OF MITOTIC CELL CYCLE |
8 |
27 |
9.098e-08 |
3.09e-06 |
138 |
POSITIVE REGULATION OF MITOTIC CELL CYCLE |
15 |
123 |
1.093e-07 |
3.659e-06 |
139 |
ENDOCRINE SYSTEM DEVELOPMENT |
15 |
123 |
1.093e-07 |
3.659e-06 |
140 |
POSITIVE REGULATION OF CELL DEATH |
36 |
605 |
1.125e-07 |
3.738e-06 |
141 |
RESPONSE TO GROWTH FACTOR |
31 |
475 |
1.182e-07 |
3.901e-06 |
142 |
REGULATION OF KINASE ACTIVITY |
42 |
776 |
1.327e-07 |
4.348e-06 |
143 |
PHOSPHORYLATION |
57 |
1228 |
1.393e-07 |
4.534e-06 |
144 |
MRNA METABOLIC PROCESS |
36 |
611 |
1.433e-07 |
4.631e-06 |
145 |
REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR |
17 |
162 |
1.456e-07 |
4.671e-06 |
146 |
POSITIVE REGULATION OF GENE EXPRESSION EPIGENETIC |
12 |
78 |
1.571e-07 |
5.007e-06 |
147 |
IN UTERO EMBRYONIC DEVELOPMENT |
24 |
311 |
1.616e-07 |
5.115e-06 |
148 |
DNA REPLICATION INITIATION |
8 |
29 |
1.691e-07 |
5.317e-06 |
149 |
CENTRAL NERVOUS SYSTEM DEVELOPMENT |
45 |
872 |
1.805e-07 |
5.636e-06 |
150 |
REGULATION OF HISTONE PHOSPHORYLATION |
6 |
13 |
1.835e-07 |
5.692e-06 |
151 |
CHROMATIN SILENCING |
13 |
95 |
1.978e-07 |
6.096e-06 |
152 |
SOMATIC STEM CELL POPULATION MAINTENANCE |
11 |
66 |
2.234e-07 |
6.838e-06 |
153 |
REGULATION OF MULTICELLULAR ORGANISMAL DEVELOPMENT |
70 |
1672 |
2.454e-07 |
7.441e-06 |
154 |
POSITIVE REGULATION OF CELL DIFFERENTIATION |
43 |
823 |
2.463e-07 |
7.441e-06 |
155 |
DNA TEMPLATED TRANSCRIPTION ELONGATION |
13 |
97 |
2.537e-07 |
7.617e-06 |
156 |
MACROMOLECULE DEACYLATION |
11 |
67 |
2.619e-07 |
7.813e-06 |
157 |
MAINTENANCE OF CELL NUMBER |
15 |
132 |
2.794e-07 |
8.28e-06 |
158 |
CELLULAR RESPONSE TO ALCOHOL |
14 |
115 |
2.965e-07 |
8.732e-06 |
159 |
POSITIVE REGULATION OF CELL CYCLE PHASE TRANSITION |
11 |
68 |
3.063e-07 |
8.963e-06 |
160 |
DNA DEPENDENT DNA REPLICATION |
13 |
99 |
3.234e-07 |
9.379e-06 |
161 |
REGULATION OF MUSCLE CELL DIFFERENTIATION |
16 |
152 |
3.245e-07 |
9.379e-06 |
162 |
CELLULAR RESPONSE TO HORMONE STIMULUS |
33 |
552 |
3.48e-07 |
9.996e-06 |
163 |
POSTTRANSCRIPTIONAL REGULATION OF GENE EXPRESSION |
29 |
448 |
3.614e-07 |
1.032e-05 |
164 |
PROTEIN COMPLEX SUBUNIT ORGANIZATION |
65 |
1527 |
3.943e-07 |
1.119e-05 |
165 |
EPITHELIAL TO MESENCHYMAL TRANSITION |
10 |
56 |
4.077e-07 |
1.15e-05 |
166 |
REGULATION OF RESPONSE TO STRESS |
63 |
1468 |
4.616e-07 |
1.294e-05 |
167 |
INTRACELLULAR SIGNAL TRANSDUCTION |
66 |
1572 |
5.176e-07 |
1.442e-05 |
168 |
PROTEIN LOCALIZATION TO CHROMOSOME |
9 |
45 |
5.678e-07 |
1.573e-05 |
169 |
PROTEIN ACYLATION |
16 |
159 |
6e-07 |
1.652e-05 |
170 |
ODONTOGENESIS |
13 |
105 |
6.462e-07 |
1.769e-05 |
171 |
REGULATION OF CELL CYCLE G2 M PHASE TRANSITION |
10 |
59 |
6.775e-07 |
1.84e-05 |
172 |
NEGATIVE REGULATION OF DNA BINDING |
9 |
46 |
6.921e-07 |
1.84e-05 |
173 |
RESPONSE TO EXTERNAL STIMULUS |
73 |
1821 |
6.862e-07 |
1.84e-05 |
174 |
HISTONE H3 ACETYLATION |
9 |
46 |
6.921e-07 |
1.84e-05 |
175 |
REGULATION OF PHOSPHORUS METABOLIC PROCESS |
67 |
1618 |
6.858e-07 |
1.84e-05 |
176 |
ATP DEPENDENT CHROMATIN REMODELING |
11 |
74 |
7.401e-07 |
1.957e-05 |
177 |
RESPONSE TO RADIATION |
27 |
413 |
7.597e-07 |
1.997e-05 |
178 |
SENSORY ORGAN DEVELOPMENT |
30 |
493 |
8.334e-07 |
2.179e-05 |
179 |
HISTONE PHOSPHORYLATION |
7 |
25 |
9.154e-07 |
2.38e-05 |
180 |
REGULATION OF VIRAL TRANSCRIPTION |
10 |
61 |
9.343e-07 |
2.415e-05 |
181 |
REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY |
29 |
470 |
9.635e-07 |
2.477e-05 |
182 |
REGULATION OF HOMEOSTATIC PROCESS |
28 |
447 |
1.106e-06 |
2.828e-05 |
183 |
ORGAN MORPHOGENESIS |
42 |
841 |
1.117e-06 |
2.84e-05 |
184 |
PEPTIDYL SERINE MODIFICATION |
15 |
148 |
1.23e-06 |
3.111e-05 |
185 |
RNA CAPPING |
8 |
37 |
1.3e-06 |
3.252e-05 |
186 |
X7 METHYLGUANOSINE RNA CAPPING |
8 |
37 |
1.3e-06 |
3.252e-05 |
187 |
STEM CELL DIFFERENTIATION |
17 |
190 |
1.407e-06 |
3.502e-05 |
188 |
NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS |
34 |
616 |
1.417e-06 |
3.508e-05 |
189 |
REGULATION OF CATABOLIC PROCESS |
38 |
731 |
1.44e-06 |
3.544e-05 |
190 |
REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING |
9 |
50 |
1.454e-06 |
3.561e-05 |
191 |
NUCLEOTIDE EXCISION REPAIR |
13 |
113 |
1.511e-06 |
3.681e-05 |
192 |
MESENCHYMAL CELL DIFFERENTIATION |
14 |
134 |
1.934e-06 |
4.687e-05 |
193 |
POSITIVE REGULATION OF VIRAL TRANSCRIPTION |
8 |
39 |
1.992e-06 |
4.752e-05 |
194 |
CELLULAR RESPONSE TO UV |
10 |
66 |
1.978e-06 |
4.752e-05 |
195 |
BASE EXCISION REPAIR |
8 |
39 |
1.992e-06 |
4.752e-05 |
196 |
TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER |
11 |
82 |
2.111e-06 |
5.012e-05 |
197 |
CELLULAR RESPONSE TO ABIOTIC STIMULUS |
20 |
263 |
2.189e-06 |
5.17e-05 |
198 |
NEGATIVE REGULATION OF SEQUENCE SPECIFIC DNA BINDING TRANSCRIPTION FACTOR ACTIVITY |
14 |
136 |
2.31e-06 |
5.428e-05 |
199 |
ESTABLISHMENT OF PROTEIN LOCALIZATION TO ORGANELLE |
24 |
361 |
2.349e-06 |
5.491e-05 |
200 |
ORGAN REGENERATION |
11 |
83 |
2.385e-06 |
5.55e-05 |
201 |
CELLULAR RESPONSE TO RADIATION |
14 |
137 |
2.521e-06 |
5.836e-05 |
202 |
LEUKOCYTE DIFFERENTIATION |
21 |
292 |
2.973e-06 |
6.847e-05 |
203 |
MITOTIC SPINDLE ORGANIZATION |
10 |
69 |
3.003e-06 |
6.883e-05 |
204 |
REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION |
66 |
1656 |
3.121e-06 |
7.119e-05 |
205 |
NEGATIVE REGULATION OF DNA REPLICATION |
9 |
55 |
3.342e-06 |
7.585e-05 |
206 |
PROTEIN COMPLEX BIOGENESIS |
50 |
1132 |
3.615e-06 |
8.114e-05 |
207 |
MYELOID DENDRITIC CELL DIFFERENTIATION |
6 |
20 |
3.627e-06 |
8.114e-05 |
208 |
PROTEIN COMPLEX ASSEMBLY |
50 |
1132 |
3.615e-06 |
8.114e-05 |
209 |
REGULATION OF MESENCHYMAL CELL APOPTOTIC PROCESS |
5 |
12 |
3.836e-06 |
8.54e-05 |
210 |
REGULATION OF HISTONE METHYLATION |
9 |
56 |
3.904e-06 |
8.608e-05 |
211 |
POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS |
50 |
1135 |
3.891e-06 |
8.608e-05 |
212 |
CELLULAR RESPONSE TO OXYGEN LEVELS |
14 |
143 |
4.19e-06 |
9.169e-05 |
213 |
TUBE MORPHOGENESIS |
22 |
323 |
4.197e-06 |
9.169e-05 |
214 |
REGULATION OF STEM CELL PROLIFERATION |
11 |
88 |
4.278e-06 |
9.302e-05 |
215 |
REGULATION OF CYTOKINE PRODUCTION |
31 |
563 |
4.381e-06 |
9.438e-05 |
216 |
NEUROGENESIS |
58 |
1402 |
4.366e-06 |
9.438e-05 |
217 |
NEGATIVE REGULATION OF TRANSFERASE ACTIVITY |
23 |
351 |
4.845e-06 |
0.0001039 |
218 |
RESPONSE TO UV |
13 |
126 |
5.164e-06 |
0.0001098 |
219 |
LYMPHOCYTE DIFFERENTIATION |
17 |
209 |
5.166e-06 |
0.0001098 |
220 |
CELL ACTIVATION |
31 |
568 |
5.237e-06 |
0.0001108 |
221 |
CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION |
29 |
513 |
5.417e-06 |
0.0001141 |
222 |
INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS |
7 |
32 |
5.597e-06 |
0.0001173 |
223 |
CELLULAR RESPONSE TO LIGHT STIMULUS |
11 |
91 |
5.956e-06 |
0.0001243 |
224 |
PROTEIN LOCALIZATION TO CHROMATIN |
5 |
13 |
6.119e-06 |
0.0001271 |
225 |
ODONTOGENESIS OF DENTIN CONTAINING TOOTH |
10 |
75 |
6.495e-06 |
0.0001343 |
226 |
POSITIVE REGULATION OF VIRAL PROCESS |
11 |
92 |
6.631e-06 |
0.0001365 |
227 |
ENDOCARDIAL CUSHION MORPHOGENESIS |
6 |
22 |
6.721e-06 |
0.0001378 |
228 |
NEGATIVE REGULATION OF DNA METABOLIC PROCESS |
12 |
111 |
7.329e-06 |
0.0001496 |
229 |
BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE |
13 |
131 |
7.938e-06 |
0.0001613 |
230 |
CELLULAR MACROMOLECULAR COMPLEX ASSEMBLY |
36 |
727 |
8.115e-06 |
0.0001642 |
231 |
ANAPHASE PROMOTING COMPLEX DEPENDENT CATABOLIC PROCESS |
10 |
77 |
8.259e-06 |
0.0001664 |
232 |
REGULATION OF APOPTOTIC SIGNALING PATHWAY |
23 |
363 |
8.407e-06 |
0.0001686 |
233 |
INTRINSIC APOPTOTIC SIGNALING PATHWAY |
14 |
152 |
8.538e-06 |
0.0001705 |
234 |
POSITIVE REGULATION OF CELL DIVISION |
13 |
132 |
8.629e-06 |
0.0001709 |
235 |
NEGATIVE REGULATION OF MITOTIC NUCLEAR DIVISION |
7 |
34 |
8.606e-06 |
0.0001709 |
236 |
THYMUS DEVELOPMENT |
8 |
47 |
8.702e-06 |
0.0001716 |
237 |
POSITIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING |
5 |
14 |
9.343e-06 |
0.0001834 |
238 |
NEGATIVE REGULATION OF CELL PROLIFERATION |
33 |
643 |
9.423e-06 |
0.0001842 |
239 |
HOMEOSTASIS OF NUMBER OF CELLS |
15 |
175 |
9.848e-06 |
0.0001917 |
240 |
REGULATION OF PROTEIN CATABOLIC PROCESS |
24 |
393 |
9.953e-06 |
0.000193 |
241 |
MYELOID LEUKOCYTE DIFFERENTIATION |
11 |
96 |
1.004e-05 |
0.0001939 |
242 |
POSITIVE REGULATION OF TRANSFERASE ACTIVITY |
32 |
616 |
1.011e-05 |
0.0001944 |
243 |
POSITIVE REGULATION OF RESPONSE TO STIMULUS |
72 |
1929 |
1.052e-05 |
0.0002012 |
244 |
SISTER CHROMATID SEGREGATION |
15 |
176 |
1.055e-05 |
0.0002012 |
245 |
PROTEIN LOCALIZATION TO NUCLEUS |
14 |
156 |
1.151e-05 |
0.0002186 |
246 |
HEAD DEVELOPMENT |
35 |
709 |
1.161e-05 |
0.0002197 |
247 |
TISSUE DEVELOPMENT |
60 |
1518 |
1.195e-05 |
0.000225 |
248 |
POSITIVE REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY |
7 |
36 |
1.285e-05 |
0.000241 |
249 |
CHROMOSOME SEGREGATION |
19 |
272 |
1.326e-05 |
0.0002478 |
250 |
REGULATION OF CELL DEVELOPMENT |
39 |
836 |
1.343e-05 |
0.00025 |
251 |
CELLULAR COMPONENT MORPHOGENESIS |
41 |
900 |
1.403e-05 |
0.000258 |
252 |
RESPONSE TO GAMMA RADIATION |
8 |
50 |
1.401e-05 |
0.000258 |
253 |
MULTI ORGANISM METABOLIC PROCESS |
13 |
138 |
1.4e-05 |
0.000258 |
254 |
SPINDLE CHECKPOINT |
6 |
25 |
1.507e-05 |
0.0002761 |
255 |
NEGATIVE REGULATION OF RESPONSE TO STIMULUS |
55 |
1360 |
1.515e-05 |
0.0002764 |
256 |
MRNA PROCESSING |
25 |
432 |
1.631e-05 |
0.000293 |
257 |
CELL DEATH |
44 |
1001 |
1.623e-05 |
0.000293 |
258 |
EYE DEVELOPMENT |
21 |
326 |
1.615e-05 |
0.000293 |
259 |
NUCLEAR CHROMOSOME SEGREGATION |
17 |
228 |
1.628e-05 |
0.000293 |
260 |
REPRODUCTION |
53 |
1297 |
1.653e-05 |
0.0002958 |
261 |
REGULATION OF TELOMERE MAINTENANCE |
9 |
67 |
1.772e-05 |
0.0003148 |
262 |
REGULATION OF SISTER CHROMATID SEGREGATION |
9 |
67 |
1.772e-05 |
0.0003148 |
263 |
HISTONE METHYLATION |
10 |
84 |
1.808e-05 |
0.0003187 |
264 |
FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY |
10 |
84 |
1.808e-05 |
0.0003187 |
265 |
REGULATION OF DOUBLE STRAND BREAK REPAIR |
7 |
38 |
1.869e-05 |
0.0003269 |
266 |
MESENCHYME MORPHOGENESIS |
7 |
38 |
1.869e-05 |
0.0003269 |
267 |
MYELOID DENDRITIC CELL ACTIVATION |
6 |
26 |
1.922e-05 |
0.000335 |
268 |
EPITHELIUM DEVELOPMENT |
42 |
945 |
1.97e-05 |
0.0003421 |
269 |
REGULATION OF CHROMOSOME SEGREGATION |
10 |
85 |
2.009e-05 |
0.0003475 |
270 |
FOREBRAIN DEVELOPMENT |
22 |
357 |
2.025e-05 |
0.000349 |
271 |
EPITHELIAL CELL DIFFERENTIATION |
27 |
495 |
2.155e-05 |
0.00037 |
272 |
RESPONSE TO IONIZING RADIATION |
13 |
145 |
2.38e-05 |
0.0004072 |
273 |
TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY |
27 |
498 |
2.396e-05 |
0.0004083 |
274 |
REGULATION OF HISTONE H3 K4 METHYLATION |
6 |
27 |
2.425e-05 |
0.0004118 |
275 |
MYELOID CELL DIFFERENTIATION |
15 |
189 |
2.463e-05 |
0.0004167 |
276 |
MORPHOGENESIS OF A BRANCHING STRUCTURE |
14 |
167 |
2.49e-05 |
0.0004198 |
277 |
RESPONSE TO OXYGEN LEVELS |
20 |
311 |
2.625e-05 |
0.0004409 |
278 |
MACROMOLECULE CATABOLIC PROCESS |
41 |
926 |
2.708e-05 |
0.0004532 |
279 |
NEGATIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING |
5 |
17 |
2.732e-05 |
0.0004556 |
280 |
CARTILAGE DEVELOPMENT |
13 |
147 |
2.753e-05 |
0.0004575 |
281 |
RESPONSE TO NUTRIENT |
15 |
191 |
2.786e-05 |
0.0004614 |
282 |
APPENDAGE DEVELOPMENT |
14 |
169 |
2.844e-05 |
0.0004676 |
283 |
LIMB DEVELOPMENT |
14 |
169 |
2.844e-05 |
0.0004676 |
284 |
TISSUE MORPHOGENESIS |
28 |
533 |
2.983e-05 |
0.0004887 |
285 |
MAMMARY GLAND DUCT MORPHOGENESIS |
6 |
28 |
3.028e-05 |
0.0004944 |
286 |
CELLULAR RESPONSE TO EXTERNAL STIMULUS |
18 |
264 |
3.076e-05 |
0.0005005 |
287 |
POSITIVE REGULATION OF HOMEOSTATIC PROCESS |
16 |
216 |
3.116e-05 |
0.0005051 |
288 |
NEGATIVE REGULATION OF PHOSPHORYLATION |
24 |
422 |
3.181e-05 |
0.0005139 |
289 |
POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY |
14 |
171 |
3.242e-05 |
0.0005219 |
290 |
TRANSCRIPTION COUPLED NUCLEOTIDE EXCISION REPAIR |
9 |
73 |
3.575e-05 |
0.0005716 |
291 |
RNA SPLICING VIA TRANSESTERIFICATION REACTIONS |
18 |
267 |
3.57e-05 |
0.0005716 |
292 |
EMBRYONIC MORPHOGENESIS |
28 |
539 |
3.636e-05 |
0.0005793 |
293 |
REGULATION OF MICROTUBULE BASED PROCESS |
17 |
243 |
3.681e-05 |
0.0005845 |
294 |
POSITIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION |
5 |
18 |
3.713e-05 |
0.0005876 |
295 |
POSITIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT |
6 |
29 |
3.746e-05 |
0.0005909 |
296 |
ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY |
33 |
689 |
3.773e-05 |
0.0005911 |
297 |
POSITIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL |
15 |
196 |
3.764e-05 |
0.0005911 |
298 |
REGULATION OF PROTEIN STABILITY |
16 |
221 |
4.112e-05 |
0.0006421 |
299 |
REGULATION OF GROWTH |
31 |
633 |
4.295e-05 |
0.0006685 |
300 |
REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY |
7 |
43 |
4.332e-05 |
0.0006705 |
301 |
PROTEASOMAL PROTEIN CATABOLIC PROCESS |
18 |
271 |
4.337e-05 |
0.0006705 |
302 |
NEURON PROJECTION DEVELOPMENT |
28 |
545 |
4.415e-05 |
0.0006802 |
303 |
RHYTHMIC PROCESS |
19 |
298 |
4.672e-05 |
0.0007174 |
304 |
REGULATION OF PROTEIN LOCALIZATION |
41 |
950 |
4.821e-05 |
0.000738 |
305 |
REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY |
8 |
59 |
4.853e-05 |
0.0007403 |
306 |
NEGATIVE REGULATION OF CELL DIFFERENTIATION |
30 |
609 |
5.13e-05 |
0.0007801 |
307 |
REGULATION OF CELLULAR AMIDE METABOLIC PROCESS |
21 |
354 |
5.41e-05 |
0.0008199 |
308 |
NEGATIVE REGULATION OF CELL DIVISION |
8 |
60 |
5.491e-05 |
0.0008242 |
309 |
CHONDROCYTE DIFFERENTIATION |
8 |
60 |
5.491e-05 |
0.0008242 |
310 |
POSITIVE REGULATION OF MULTI ORGANISM PROCESS |
13 |
157 |
5.486e-05 |
0.0008242 |
311 |
REGULATION OF CELLULAR PROTEIN LOCALIZATION |
28 |
552 |
5.513e-05 |
0.0008248 |
312 |
ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS |
41 |
957 |
5.675e-05 |
0.0008455 |
313 |
RESPONSE TO ETHANOL |
12 |
136 |
5.7e-05 |
0.0008455 |
314 |
GROWTH |
23 |
410 |
5.715e-05 |
0.0008455 |
315 |
NEGATIVE REGULATION OF CATALYTIC ACTIVITY |
37 |
829 |
5.724e-05 |
0.0008455 |
316 |
NEGATIVE REGULATION OF CHROMATIN MODIFICATION |
7 |
45 |
5.87e-05 |
0.0008644 |
317 |
RESPONSE TO FIBROBLAST GROWTH FACTOR |
11 |
116 |
5.997e-05 |
0.0008803 |
318 |
REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS |
14 |
181 |
6.051e-05 |
0.0008854 |
319 |
NEGATIVE REGULATION OF CELL COMMUNICATION |
48 |
1192 |
6.112e-05 |
0.0008915 |
320 |
POSITIVE REGULATION OF STEM CELL PROLIFERATION |
8 |
61 |
6.197e-05 |
0.0009011 |
321 |
RESPONSE TO EXTRACELLULAR STIMULUS |
24 |
441 |
6.375e-05 |
0.0009212 |
322 |
REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY |
10 |
97 |
6.36e-05 |
0.0009212 |
323 |
PROTEIN METHYLATION |
11 |
117 |
6.489e-05 |
0.000929 |
324 |
MAMMARY GLAND DEVELOPMENT |
11 |
117 |
6.489e-05 |
0.000929 |
325 |
PROTEIN ALKYLATION |
11 |
117 |
6.489e-05 |
0.000929 |
326 |
RNA PROCESSING |
37 |
835 |
6.643e-05 |
0.0009481 |
327 |
ENDOCARDIAL CUSHION DEVELOPMENT |
6 |
32 |
6.752e-05 |
0.0009578 |
328 |
BONE MORPHOGENESIS |
9 |
79 |
6.733e-05 |
0.0009578 |
329 |
NEGATIVE REGULATION OF NUCLEAR DIVISION |
7 |
46 |
6.792e-05 |
0.0009605 |
330 |
DEVELOPMENTAL GROWTH |
20 |
333 |
6.842e-05 |
0.0009647 |
331 |
REGULATION OF PROTEOLYSIS |
33 |
711 |
6.927e-05 |
0.0009737 |
332 |
REGENERATION |
13 |
161 |
7.111e-05 |
0.0009966 |
333 |
REGULATION OF CYTOSKELETON ORGANIZATION |
26 |
502 |
7.227e-05 |
0.001005 |
334 |
EPITHELIAL TO MESENCHYMAL TRANSITION INVOLVED IN ENDOCARDIAL CUSHION FORMATION |
4 |
11 |
7.235e-05 |
0.001005 |
335 |
VIRAL LATENCY |
4 |
11 |
7.235e-05 |
0.001005 |
336 |
MEMBRANE DISASSEMBLY |
7 |
47 |
7.828e-05 |
0.001081 |
337 |
NUCLEAR ENVELOPE DISASSEMBLY |
7 |
47 |
7.828e-05 |
0.001081 |
338 |
DENDRITIC CELL DIFFERENTIATION |
6 |
33 |
8.098e-05 |
0.001105 |
339 |
CELLULAR SENESCENCE |
6 |
33 |
8.098e-05 |
0.001105 |
340 |
POSITIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING |
6 |
33 |
8.098e-05 |
0.001105 |
341 |
G2 DNA DAMAGE CHECKPOINT |
6 |
33 |
8.098e-05 |
0.001105 |
342 |
REGULATION OF FIBROBLAST PROLIFERATION |
9 |
81 |
8.205e-05 |
0.001116 |
343 |
HEMOSTASIS |
19 |
311 |
8.263e-05 |
0.001121 |
344 |
REGULATION OF EPITHELIAL CELL PROLIFERATION |
18 |
285 |
8.305e-05 |
0.001123 |
345 |
PLATELET ACTIVATION |
12 |
142 |
8.668e-05 |
0.001169 |
346 |
NEGATIVE REGULATION OF CYTOKINE PRODUCTION |
15 |
211 |
8.733e-05 |
0.001174 |
347 |
REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT |
7 |
48 |
8.99e-05 |
0.001201 |
348 |
REGULATION OF CANONICAL WNT SIGNALING PATHWAY |
16 |
236 |
8.985e-05 |
0.001201 |
349 |
RNA SPLICING |
21 |
367 |
9.032e-05 |
0.001201 |
350 |
SNRNA METABOLIC PROCESS |
9 |
82 |
9.037e-05 |
0.001201 |
351 |
POSITIVE REGULATION OF CYTOKINE PRODUCTION |
21 |
370 |
0.0001012 |
0.001342 |
352 |
MESENCHYME DEVELOPMENT |
14 |
190 |
0.000102 |
0.001349 |
353 |
SKELETAL SYSTEM DEVELOPMENT |
24 |
455 |
0.0001032 |
0.001357 |
354 |
POSITIVE REGULATION OF MITOCHONDRION ORGANIZATION |
13 |
167 |
0.0001033 |
0.001357 |
355 |
REGULATION OF MUSCLE TISSUE DEVELOPMENT |
10 |
103 |
0.0001059 |
0.001377 |
356 |
POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION |
10 |
103 |
0.0001059 |
0.001377 |
357 |
REGULATION OF MUSCLE ORGAN DEVELOPMENT |
10 |
103 |
0.0001059 |
0.001377 |
358 |
HISTONE H3 DEACETYLATION |
5 |
22 |
0.000106 |
0.001377 |
359 |
TRANSCRIPTION FROM RNA POLYMERASE I PROMOTER |
6 |
35 |
0.0001143 |
0.001481 |
360 |
CARDIAC CHAMBER MORPHOGENESIS |
10 |
104 |
0.0001149 |
0.001485 |
361 |
HISTONE H4 ACETYLATION |
7 |
50 |
0.0001173 |
0.001513 |
362 |
NEURON PROJECTION MORPHOGENESIS |
22 |
402 |
0.000118 |
0.001517 |
363 |
REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION |
9 |
85 |
0.0001197 |
0.001534 |
364 |
REGULATION OF ORGAN MORPHOGENESIS |
16 |
242 |
0.0001204 |
0.001539 |
365 |
REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS |
15 |
218 |
0.0001257 |
0.001603 |
366 |
CONNECTIVE TISSUE DEVELOPMENT |
14 |
194 |
0.0001273 |
0.001618 |
367 |
REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS |
12 |
148 |
0.0001288 |
0.001629 |
368 |
RESPONSE TO TRANSITION METAL NANOPARTICLE |
12 |
148 |
0.0001288 |
0.001629 |
369 |
POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION |
5 |
23 |
0.0001329 |
0.001676 |
370 |
PHOSPHATE CONTAINING COMPOUND METABOLIC PROCESS |
69 |
1977 |
0.0001339 |
0.001684 |
371 |
NEGATIVE REGULATION OF HISTONE MODIFICATION |
6 |
36 |
0.0001345 |
0.001687 |
372 |
TUBE DEVELOPMENT |
27 |
552 |
0.0001362 |
0.001699 |
373 |
EMBRYONIC ORGAN DEVELOPMENT |
22 |
406 |
0.000136 |
0.001699 |
374 |
EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING |
27 |
554 |
0.0001445 |
0.001797 |
375 |
PROTEIN LOCALIZATION TO CHROMOSOME CENTROMERIC REGION |
4 |
13 |
0.0001513 |
0.001872 |
376 |
EYELID DEVELOPMENT IN CAMERA TYPE EYE |
4 |
13 |
0.0001513 |
0.001872 |
377 |
NCRNA TRANSCRIPTION |
9 |
88 |
0.0001566 |
0.001932 |
378 |
POSITIVE REGULATION OF TYPE I INTERFERON PRODUCTION |
8 |
70 |
0.0001667 |
0.002042 |
379 |
NEURON DIFFERENTIATION |
37 |
874 |
0.0001667 |
0.002042 |
380 |
REGULATION OF MEMBRANE PERMEABILITY |
8 |
70 |
0.0001667 |
0.002042 |
381 |
REGULATION OF LIGASE ACTIVITY |
11 |
130 |
0.0001677 |
0.002048 |
382 |
POSITIVE REGULATION OF FIBROBLAST PROLIFERATION |
7 |
53 |
0.0001709 |
0.002077 |
383 |
MAMMARY GLAND EPITHELIUM DEVELOPMENT |
7 |
53 |
0.0001709 |
0.002077 |
384 |
RESPONSE TO CORTICOSTEROID |
13 |
176 |
0.0001748 |
0.002118 |
385 |
POSITIVE REGULATION OF LIGASE ACTIVITY |
10 |
110 |
0.0001833 |
0.002209 |
386 |
OSSIFICATION |
16 |
251 |
0.0001833 |
0.002209 |
387 |
INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY |
8 |
71 |
0.0001842 |
0.002215 |
388 |
RESPONSE TO WOUNDING |
27 |
563 |
0.0001874 |
0.002247 |
389 |
GAMETE GENERATION |
28 |
595 |
0.0001954 |
0.002326 |
390 |
REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION |
13 |
178 |
0.0001955 |
0.002326 |
391 |
REGULATION OF OSSIFICATION |
13 |
178 |
0.0001955 |
0.002326 |
392 |
POSITIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS |
10 |
111 |
0.0001975 |
0.002332 |
393 |
SISTER CHROMATID COHESION |
10 |
111 |
0.0001975 |
0.002332 |
394 |
REGULATION OF TYPE I INTERFERON PRODUCTION |
10 |
111 |
0.0001975 |
0.002332 |
395 |
TROPHECTODERMAL CELL DIFFERENTIATION |
4 |
14 |
0.000208 |
0.002438 |
396 |
PEPTIDYL ARGININE METHYLATION |
4 |
14 |
0.000208 |
0.002438 |
397 |
REGULATION OF HISTONE H3 K9 ACETYLATION |
4 |
14 |
0.000208 |
0.002438 |
398 |
BONE DEVELOPMENT |
12 |
156 |
0.0002114 |
0.002471 |
399 |
REGULATION OF CENTROSOME CYCLE |
6 |
39 |
0.0002129 |
0.002471 |
400 |
EAR MORPHOGENESIS |
10 |
112 |
0.0002126 |
0.002471 |
401 |
CELLULAR RESPONSE TO NUTRIENT |
6 |
39 |
0.0002129 |
0.002471 |
402 |
NEGATIVE REGULATION OF MUSCLE CELL DIFFERENTIATION |
7 |
55 |
0.0002166 |
0.002506 |
403 |
POSITIVE REGULATION OF PROTEOLYSIS |
20 |
363 |
0.0002182 |
0.00252 |
404 |
MITOCHONDRIAL MEMBRANE ORGANIZATION |
9 |
92 |
0.00022 |
0.002534 |
405 |
REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION |
8 |
73 |
0.0002239 |
0.002572 |
406 |
MACROMOLECULE METHYLATION |
14 |
205 |
0.0002265 |
0.002595 |
407 |
REGULATION OF STEM CELL DIFFERENTIATION |
10 |
113 |
0.0002286 |
0.002614 |
408 |
NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS |
26 |
541 |
0.0002377 |
0.002704 |
409 |
NEGATIVE REGULATION OF PHOSPHATE METABOLIC PROCESS |
26 |
541 |
0.0002377 |
0.002704 |
410 |
RESPONSE TO KETONE |
13 |
182 |
0.0002432 |
0.002753 |
411 |
POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT |
7 |
56 |
0.0002428 |
0.002753 |
412 |
MAMMARY GLAND MORPHOGENESIS |
6 |
40 |
0.0002458 |
0.00277 |
413 |
FEMALE MEIOTIC DIVISION |
5 |
26 |
0.0002459 |
0.00277 |
414 |
RESPONSE TO NITROGEN COMPOUND |
36 |
859 |
0.0002477 |
0.002784 |
415 |
SEXUAL REPRODUCTION |
32 |
730 |
0.0002506 |
0.00281 |
416 |
REGULATION OF DNA BIOSYNTHETIC PROCESS |
9 |
94 |
0.000259 |
0.002897 |
417 |
REGULATION OF DNA REPAIR |
8 |
75 |
0.0002703 |
0.003016 |
418 |
REGULATION OF TELOMERASE RNA LOCALIZATION TO CAJAL BODY |
4 |
15 |
0.0002787 |
0.003073 |
419 |
MALE GAMETE GENERATION |
24 |
486 |
0.0002763 |
0.003073 |
420 |
ENDOCARDIAL CUSHION FORMATION |
4 |
15 |
0.0002787 |
0.003073 |
421 |
POSITIVE REGULATION OF TELOMERASE RNA LOCALIZATION TO CAJAL BODY |
4 |
15 |
0.0002787 |
0.003073 |
422 |
HISTONE H2A ACETYLATION |
4 |
15 |
0.0002787 |
0.003073 |
423 |
NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION |
6 |
41 |
0.0002826 |
0.003079 |
424 |
MITOTIC SPINDLE ASSEMBLY |
6 |
41 |
0.0002826 |
0.003079 |
425 |
LYMPHOCYTE ACTIVATION |
19 |
342 |
0.0002809 |
0.003079 |
426 |
MICROTUBULE CYTOSKELETON ORGANIZATION INVOLVED IN MITOSIS |
6 |
41 |
0.0002826 |
0.003079 |
427 |
CELLULAR RESPONSE TO ESTROGEN STIMULUS |
6 |
41 |
0.0002826 |
0.003079 |
428 |
NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS |
34 |
801 |
0.0002919 |
0.003173 |
429 |
MORPHOGENESIS OF AN EPITHELIUM |
21 |
400 |
0.0002941 |
0.00319 |
430 |
POSITIVE REGULATION OF HEART GROWTH |
5 |
27 |
0.0002963 |
0.003198 |
431 |
INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS |
5 |
27 |
0.0002963 |
0.003198 |
432 |
REGULATION OF RNA STABILITY |
11 |
139 |
0.0003012 |
0.003231 |
433 |
APOPTOTIC SIGNALING PATHWAY |
17 |
289 |
0.0003014 |
0.003231 |
434 |
GENE SILENCING BY RNA |
11 |
139 |
0.0003012 |
0.003231 |
435 |
CELLULAR RESPONSE TO CORTICOSTEROID STIMULUS |
7 |
58 |
0.0003029 |
0.00324 |
436 |
MUSCLE CELL DIFFERENTIATION |
15 |
237 |
0.000312 |
0.003329 |
437 |
VIRAL LIFE CYCLE |
17 |
290 |
0.0003137 |
0.00334 |
438 |
HEART MORPHOGENESIS |
14 |
212 |
0.0003195 |
0.003394 |
439 |
CYTOSKELETON ORGANIZATION |
35 |
838 |
0.0003214 |
0.003406 |
440 |
PITUITARY GLAND DEVELOPMENT |
6 |
42 |
0.0003235 |
0.003406 |
441 |
POSITIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION |
6 |
42 |
0.0003235 |
0.003406 |
442 |
REGULATION OF HEART GROWTH |
6 |
42 |
0.0003235 |
0.003406 |
443 |
GLAND MORPHOGENESIS |
9 |
97 |
0.0003281 |
0.003447 |
444 |
PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL |
36 |
873 |
0.000336 |
0.003521 |
445 |
POSITIVE REGULATION OF DNA BIOSYNTHETIC PROCESS |
7 |
59 |
0.0003371 |
0.003525 |
446 |
SENSORY ORGAN MORPHOGENESIS |
15 |
239 |
0.0003412 |
0.003559 |
447 |
MICROTUBULE CYTOSKELETON ORGANIZATION |
19 |
348 |
0.0003489 |
0.003632 |
448 |
NEGATIVE REGULATION OF CHROMOSOME SEGREGATION |
5 |
28 |
0.0003541 |
0.003678 |
449 |
POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS |
21 |
406 |
0.0003585 |
0.003715 |
450 |
REGULATION OF MAMMARY GLAND EPITHELIAL CELL PROLIFERATION |
4 |
16 |
0.000365 |
0.003749 |
451 |
DNA LIGATION |
4 |
16 |
0.000365 |
0.003749 |
452 |
CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT |
4 |
16 |
0.000365 |
0.003749 |
453 |
V D J RECOMBINATION |
4 |
16 |
0.000365 |
0.003749 |
454 |
REGULATION OF TELOMERASE ACTIVITY |
6 |
43 |
0.000369 |
0.003782 |
455 |
HEART DEVELOPMENT |
23 |
466 |
0.0003712 |
0.003796 |
456 |
REGULATION OF PROTEIN COMPLEX DISASSEMBLY |
14 |
217 |
0.0004045 |
0.004127 |
457 |
CARDIAC CHAMBER DEVELOPMENT |
11 |
144 |
0.0004081 |
0.004146 |
458 |
PROTEIN AUTOPHOSPHORYLATION |
13 |
192 |
0.0004081 |
0.004146 |
459 |
NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS |
39 |
983 |
0.0004101 |
0.004157 |
460 |
NEURON DEVELOPMENT |
30 |
687 |
0.0004149 |
0.004188 |
461 |
EMBRYONIC DIGIT MORPHOGENESIS |
7 |
61 |
0.0004149 |
0.004188 |
462 |
WOUND HEALING |
23 |
470 |
0.0004183 |
0.004203 |
463 |
INTRACELLULAR RECEPTOR SIGNALING PATHWAY |
12 |
168 |
0.0004177 |
0.004203 |
464 |
REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION |
6 |
44 |
0.0004193 |
0.004204 |
465 |
REGULATION OF EPITHELIAL CELL DIFFERENTIATION |
10 |
122 |
0.0004247 |
0.00425 |
466 |
REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY |
11 |
145 |
0.0004329 |
0.004323 |
467 |
RESPONSE TO BIOTIC STIMULUS |
36 |
886 |
0.0004422 |
0.004406 |
468 |
NUCLEAR TRANSPORT |
19 |
355 |
0.000446 |
0.004434 |
469 |
ANTERIOR POSTERIOR PATTERN SPECIFICATION |
13 |
194 |
0.0004506 |
0.00447 |
470 |
T CELL DIFFERENTIATION |
10 |
123 |
0.0004533 |
0.004487 |
471 |
CARDIAC VENTRICLE MORPHOGENESIS |
7 |
62 |
0.0004588 |
0.004514 |
472 |
BLASTOCYST DEVELOPMENT |
7 |
62 |
0.0004588 |
0.004514 |
473 |
POSITIVE REGULATION OF NUCLEAR DIVISION |
7 |
62 |
0.0004588 |
0.004514 |
474 |
REGULATION OF CHROMATIN BINDING |
4 |
17 |
0.0004689 |
0.004584 |
475 |
NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING |
4 |
17 |
0.0004689 |
0.004584 |
476 |
REGULATION OF STEM CELL POPULATION MAINTENANCE |
4 |
17 |
0.0004689 |
0.004584 |
477 |
EAR DEVELOPMENT |
13 |
195 |
0.0004732 |
0.004616 |
478 |
EXOCRINE SYSTEM DEVELOPMENT |
6 |
45 |
0.0004747 |
0.004621 |
479 |
NEGATIVE REGULATION OF CYTOSKELETON ORGANIZATION |
14 |
221 |
0.0004857 |
0.004718 |
480 |
REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS |
16 |
274 |
0.0004872 |
0.004723 |
481 |
BLASTOCYST FORMATION |
5 |
30 |
0.0004949 |
0.004757 |
482 |
RESPONSE TO EPIDERMAL GROWTH FACTOR |
5 |
30 |
0.0004949 |
0.004757 |
483 |
CELLULAR RESPONSE TO ESTRADIOL STIMULUS |
5 |
30 |
0.0004949 |
0.004757 |
484 |
CELLULAR MACROMOLECULE LOCALIZATION |
46 |
1234 |
0.0004931 |
0.004757 |
485 |
DIGESTIVE SYSTEM DEVELOPMENT |
11 |
148 |
0.000515 |
0.004932 |
486 |
STEROID HORMONE MEDIATED SIGNALING PATHWAY |
10 |
125 |
0.0005151 |
0.004932 |
487 |
PATTERN SPECIFICATION PROCESS |
21 |
418 |
0.0005249 |
0.005015 |
488 |
POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION |
19 |
360 |
0.000529 |
0.005044 |
489 |
DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION |
27 |
602 |
0.0005339 |
0.005081 |
490 |
NEGATIVE REGULATION OF KINASE ACTIVITY |
15 |
250 |
0.0005473 |
0.005197 |
491 |
NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY |
10 |
126 |
0.0005486 |
0.005199 |
492 |
REGULATION OF CELLULAR LOCALIZATION |
47 |
1277 |
0.0005639 |
0.005333 |
493 |
CHROMOSOME CONDENSATION |
5 |
31 |
0.0005793 |
0.005456 |
494 |
RNA STABILIZATION |
5 |
31 |
0.0005793 |
0.005456 |
495 |
POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION |
8 |
84 |
0.0005864 |
0.005513 |
496 |
OOCYTE MATURATION |
4 |
18 |
0.0005923 |
0.005557 |
497 |
POSITIVE REGULATION OF TELOMERE MAINTENANCE |
6 |
47 |
0.0006027 |
0.005642 |
498 |
POSITIVE REGULATION OF CELL COMMUNICATION |
54 |
1532 |
0.0006102 |
0.005702 |
499 |
REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL |
16 |
280 |
0.0006161 |
0.005733 |
500 |
RESPONSE TO LIGHT STIMULUS |
16 |
280 |
0.0006161 |
0.005733 |
501 |
CELL FATE COMMITMENT |
14 |
227 |
0.0006333 |
0.005847 |
502 |
RNA CATABOLIC PROCESS |
14 |
227 |
0.0006333 |
0.005847 |
503 |
CELLULAR COMPONENT DISASSEMBLY |
24 |
515 |
0.0006327 |
0.005847 |
504 |
SKELETAL SYSTEM MORPHOGENESIS |
13 |
201 |
0.0006298 |
0.005847 |
505 |
EPHRIN RECEPTOR SIGNALING PATHWAY |
8 |
85 |
0.0006349 |
0.00585 |
506 |
POSITIVE REGULATION OF CATABOLIC PROCESS |
20 |
395 |
0.0006422 |
0.005905 |
507 |
POSITIVE REGULATION OF SEQUENCE SPECIFIC DNA BINDING TRANSCRIPTION FACTOR ACTIVITY |
14 |
228 |
0.0006613 |
0.006069 |
508 |
METHYLATION |
16 |
284 |
0.0007173 |
0.00657 |
509 |
SINGLE ORGANISM CELL ADHESION |
22 |
459 |
0.00073 |
0.006661 |
510 |
CELLULAR RESPONSE TO GAMMA RADIATION |
4 |
19 |
0.0007371 |
0.006661 |
511 |
REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION |
4 |
19 |
0.0007371 |
0.006661 |
512 |
REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION |
4 |
19 |
0.0007371 |
0.006661 |
513 |
PEPTIDYL ARGININE MODIFICATION |
4 |
19 |
0.0007371 |
0.006661 |
514 |
POSITIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION |
4 |
19 |
0.0007371 |
0.006661 |
515 |
REGULATION OF DNA TEMPLATED TRANSCRIPTION IN RESPONSE TO STRESS |
7 |
67 |
0.0007373 |
0.006661 |
516 |
ANATOMICAL STRUCTURE HOMEOSTASIS |
16 |
285 |
0.0007448 |
0.006716 |
517 |
REGULATION OF SYMBIOSIS ENCOMPASSING MUTUALISM THROUGH PARASITISM |
13 |
205 |
0.0007569 |
0.006812 |
518 |
MICROTUBULE BASED PROCESS |
24 |
522 |
0.0007634 |
0.006857 |
519 |
REGULATION OF HEMOPOIESIS |
17 |
314 |
0.0007725 |
0.006926 |
520 |
MEIOSIS I |
8 |
88 |
0.0008001 |
0.00716 |
521 |
REGULATION OF NERVOUS SYSTEM DEVELOPMENT |
31 |
750 |
0.0008308 |
0.007419 |
522 |
LYMPHOCYTE HOMEOSTASIS |
6 |
50 |
0.000843 |
0.007514 |
523 |
REGULATION OF INTRACELLULAR TRANSPORT |
27 |
621 |
0.0008513 |
0.007573 |
524 |
PROTEIN UBIQUITINATION INVOLVED IN UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS |
10 |
134 |
0.0008867 |
0.007873 |
525 |
HORMONE MEDIATED SIGNALING PATHWAY |
11 |
158 |
0.0008884 |
0.007874 |
526 |
T CELL HOMEOSTASIS |
5 |
34 |
0.0008978 |
0.007927 |
527 |
ORGAN FORMATION |
5 |
34 |
0.0008978 |
0.007927 |
528 |
REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION |
4 |
20 |
0.0009052 |
0.007947 |
529 |
BRANCHING INVOLVED IN MAMMARY GLAND DUCT MORPHOGENESIS |
4 |
20 |
0.0009052 |
0.007947 |
530 |
INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY |
4 |
20 |
0.0009052 |
0.007947 |
531 |
POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS |
15 |
263 |
0.00092 |
0.008024 |
532 |
REGULATION OF MAP KINASE ACTIVITY |
17 |
319 |
0.0009195 |
0.008024 |
533 |
CARDIOVASCULAR SYSTEM DEVELOPMENT |
32 |
788 |
0.0009209 |
0.008024 |
534 |
CIRCULATORY SYSTEM DEVELOPMENT |
32 |
788 |
0.0009209 |
0.008024 |
535 |
NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION |
21 |
437 |
0.0009259 |
0.008052 |
536 |
SPINDLE ASSEMBLY |
7 |
70 |
0.0009597 |
0.008331 |
537 |
NUCLEUS ORGANIZATION |
10 |
136 |
0.0009936 |
0.00861 |
538 |
REGULATION OF PROTEIN OLIGOMERIZATION |
5 |
35 |
0.001028 |
0.008883 |
539 |
MEIOTIC CELL CYCLE |
12 |
186 |
0.001029 |
0.008883 |
540 |
POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY |
6 |
52 |
0.00104 |
0.008963 |
541 |
CELL FATE SPECIFICATION |
7 |
71 |
0.001044 |
0.008983 |
542 |
MRNA TRANSCRIPTION |
4 |
21 |
0.001099 |
0.009379 |
543 |
COCHLEA MORPHOGENESIS |
4 |
21 |
0.001099 |
0.009379 |
544 |
NEGATIVE REGULATION OF PROTEIN ACETYLATION |
4 |
21 |
0.001099 |
0.009379 |
545 |
EPITHELIAL STRUCTURE MAINTENANCE |
4 |
21 |
0.001099 |
0.009379 |
546 |
CELLULAR RESPONSE TO NITROGEN COMPOUND |
23 |
505 |
0.001106 |
0.00943 |
547 |
CELL PART MORPHOGENESIS |
27 |
633 |
0.001127 |
0.009591 |
548 |
REGULATION OF BODY FLUID LEVELS |
23 |
506 |
0.001136 |
0.009625 |
549 |
PROTEIN SUMOYLATION |
9 |
115 |
0.001135 |
0.009625 |
550 |
LEUKOCYTE ACTIVATION |
20 |
414 |
0.001141 |
0.00965 |
551 |
POSITIVE REGULATION OF HEMOPOIESIS |
11 |
163 |
0.001146 |
0.009661 |
552 |
CELLULAR RESPONSE TO BIOTIC STIMULUS |
11 |
163 |
0.001146 |
0.009661 |
553 |
REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE |
6 |
53 |
0.001151 |
0.009686 |
554 |
POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS |
34 |
867 |
0.001166 |
0.00979 |
555 |
REGULATION OF ERYTHROCYTE DIFFERENTIATION |
5 |
36 |
0.001173 |
0.00983 |